Relative BCR-activation was then calculated as the percentage of CD83+ CLL cells in response to IgM-cross-linking after 48 h in IL-10 or IL-4 divided by the percentage of CLL cells cultured only in serum-free media prior to IgM-cross-linking. The gene discussed is CD83; the disease is B-cell chronic lymphocytic leukemia.